Literature DB >> 30667566

Prognostic value of the PaO2 /FiO2 ratio determined at the end-surgery stage of a double-lung transplantation.

Julien Fessler1,2, Jacques Thes3, Romain Pirracchio4,5, Mathieu Godement6,7, Edouard Sage2,8, Antoine Roux2,9, François Parquin2,8, Charles Cerf10, Marc Fischler1,2, Morgan Le Guen1,2.   

Abstract

INTRODUCTION: We evaluated the prognostic role of the arterial oxygen partial pressure/fractional inspired oxygen ratio (PaO2 /FiO2 ratio) measured at the end of double-lung transplantation (DLT).
METHODS: This was a monocentric cohort study of all consecutive DLT patients between January 1, 2012, and January 1, 2016, except patients with preoperative extracorporeal membrane oxygenation (ECMO), intraoperative cardiopulmonary bypass, postoperative ECMO, large patent foramen ovale, redo transplantation during the study period, and multiorgan transplantation.
RESULTS: A total of 164 patients were included in the study; 45 had a PaO2 /FiO2 ratio <200, 39 a ratio in the range 200-300, and 80 a ratio >300. The risk of being in the lower ratio group is positively related to body mass index, preoperative pulmonary hypertension, and fibrosis. It is negatively related to emergency surgery, age, and intraoperative institution of ECMO. There was a trend for more grade 3 pulmonary graft dysfunction at day 3 in the worst PaO2 /FiO2 ratio group. Mortality at 1000 days was similar for all patients and even after exclusion of patients who had required intraoperative ECMO.
CONCLUSION: PaO2 /FiO2 ratio measured at the end of DLT does not forecast 1000-day mortality.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  double-lung transplantation; extracorporeal membrane oxygenation; lung transplantation; oxygenation

Year:  2019        PMID: 30667566     DOI: 10.1111/ctr.13484

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  1 in total

1.  Impact of extracorporeal membrane oxygenation in lung transplantation.

Authors:  Diego Corsetti Mondadori; William Lorenzi; Marlova Luzzi Caramori; Cristiano Feijó Andrade; Maurício Guidi Saueressig
Journal:  J Bras Pneumol       Date:  2021-01-22       Impact factor: 2.624

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.